Squarepoint’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,100
Closed -$1.09M 4999
2025
Q3
$1.09M Buy
11,100
+7,300
+192% +$723K ﹤0.01% 2621
2025
Q2
$347K Buy
+3,800
New +$367K ﹤0.01% 3575
2025
Q1
Sell
-7,400
Closed -$782K 5549
2024
Q4
$782K Buy
+7,400
New +$794K ﹤0.01% 3305
2023
Q3
Sell
-3,700
Closed -$539K 4328
2023
Q2
$539K Sell
3,700
-8,600
-70% -$1.17M ﹤0.01% 2576
2023
Q1
$1.59M Buy
12,300
+3,400
+38% +$427K 0.01% 1574
2022
Q4
$1.13M Buy
+8,900
New +$1.03M ﹤0.01% 1735

Other funds holding ZBH

Squarepoint's ZBH Position: Q2 2026 in Review

Squarepoint reduced its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, selling an estimated $459K and leaving 37,057 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Squarepoint first reported a position in ZBH in Q1 2015 and has held it in 39 quarters since. The position peaked at $37.6M in Q2 2019. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Squarepoint held 37,057 shares of Zimmer Biomet worth $3.19M as of Q2 2026.
  • Squarepoint sold 5,236 Zimmer Biomet shares in Q2 2026, an estimated $459K.
  • Zimmer Biomet made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1962 holding.
  • Squarepoint first reported a position in Zimmer Biomet in Q1 2015 and has held it in 39 quarters since.
  • Squarepoint's Zimmer Biomet position peaked at $37.6M in Q2 2019.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.